PT97277A - Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante - Google Patents

Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante

Info

Publication number
PT97277A
PT97277A PT97277A PT9727791A PT97277A PT 97277 A PT97277 A PT 97277A PT 97277 A PT97277 A PT 97277A PT 9727791 A PT9727791 A PT 9727791A PT 97277 A PT97277 A PT 97277A
Authority
PT
Portugal
Prior art keywords
cyclosporin
xenoenxerto
aloenxerto
concording
collateral
Prior art date
Application number
PT97277A
Other languages
English (en)
Other versions
PT97277B (pt
Inventor
David James Graham White
Johan Beyers Van Den Bogaerde
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of PT97277A publication Critical patent/PT97277A/pt
Publication of PT97277B publication Critical patent/PT97277B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97277A 1990-04-09 1991-04-08 Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante PT97277B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
PT97277A true PT97277A (pt) 1992-01-31
PT97277B PT97277B (pt) 1998-08-31

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97277A PT97277B (pt) 1990-04-09 1991-04-08 Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante

Country Status (22)

Country Link
EP (1) EP0527762B1 (pt)
JP (1) JP3518547B2 (pt)
CN (1) CN1040178C (pt)
AT (1) ATE141167T1 (pt)
AU (1) AU7555591A (pt)
CZ (1) CZ283119B6 (pt)
DE (1) DE69121401T2 (pt)
DK (1) DK0527762T3 (pt)
ES (1) ES2090325T3 (pt)
GB (1) GB9007971D0 (pt)
GR (1) GR3021642T3 (pt)
HK (1) HK48597A (pt)
IE (1) IE911153A1 (pt)
IL (1) IL97788A (pt)
IN (1) IN173149B (pt)
MY (1) MY106158A (pt)
NZ (1) NZ237739A (pt)
PT (1) PT97277B (pt)
SG (1) SG47465A1 (pt)
SK (1) SK279949B6 (pt)
WO (1) WO1991015221A1 (pt)
ZA (1) ZA912467B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE297217T1 (de) 1999-10-27 2005-06-15 Alexandra Lucas Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
JP2004509171A (ja) 2000-09-29 2004-03-25 ゾーン、　ロバート　ズィー． 炎症及び免疫反応の治療方法及びその組成物
EP3056218A1 (en) * 2004-05-14 2016-08-17 Alexion Pharmaceuticals, Inc. Prolongation of survival of an allograft by inhibiting complement activity
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
ES2831325T3 (es) 2006-10-10 2021-06-08 Regenesance B V Inhibición del complemento para una mejor regeneración de los nervios
EP3101031A1 (en) * 2008-11-10 2016-12-07 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
CN105683759B (zh) 2013-08-07 2019-03-29 瑞颂医药公司 非典型溶血性尿毒综合征(aHUS)生物标志物蛋白

Also Published As

Publication number Publication date
DE69121401D1 (de) 1996-09-19
SK279949B6 (sk) 1999-06-11
AU7555591A (en) 1991-10-30
ATE141167T1 (de) 1996-08-15
JPH05507266A (ja) 1993-10-21
NZ237739A (en) 1993-09-27
JP3518547B2 (ja) 2004-04-12
DE69121401T2 (de) 1996-12-12
ZA912467B (en) 1992-12-30
EP0527762A1 (en) 1993-02-24
WO1991015221A1 (en) 1991-10-17
IN173149B (pt) 1994-02-19
GR3021642T3 (en) 1997-02-28
PT97277B (pt) 1998-08-31
IL97788A0 (en) 1992-06-21
CZ283119B6 (cs) 1998-01-14
IL97788A (en) 1998-02-08
SG47465A1 (en) 1998-04-17
CN1040178C (zh) 1998-10-14
ES2090325T3 (es) 1996-10-16
DK0527762T3 (da) 1996-09-02
EP0527762B1 (en) 1996-08-14
CN1056240A (zh) 1991-11-20
MY106158A (en) 1995-03-31
CS9100988A2 (en) 1991-12-17
IE911153A1 (en) 1991-10-09
HK48597A (en) 1997-04-25
GB9007971D0 (en) 1990-06-06

Similar Documents

Publication Publication Date Title
IT8720689A0 (it) Procedimento e impianto per la separazione di sostanze leggere da miscele di substrati.
BR9306249A (pt) Processo e aparelho para segurar um instrumento médico
ES2085299T3 (es) Uso de rapamicina y sus derivados y profarmacos en la fabricacion de un medicamento para inhibir el rechazo de los transplantes en los mamiferos.
ES2016585B3 (es) Polibutilaminas y poliisobutilaminas, procedimiento para su preparacion y composiciones combustibles y lubricantes que contienen estas sustancias.
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
ES2063013T3 (es) Procedimiento para eliminar pirogenos.
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
ES2179052T3 (es) Composicion farmaceutica que contiene un derivado de ciclosporina.
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
PT97277A (pt) Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante
ES2065698T3 (es) Autobioticos y su utilizacion para eliminar in vivo celulas extrañas.
DE3750493D1 (de) Flüssige sterilisierende Zusammensetzung.
HUT54893A (en) Use of 5-adenosylmethionine for treating pancreatitis and for preventing rejection of transplanted pancreas
ES2187534T3 (es) Procedimiento para la preparacion de n-metil-3-(metil-4-piperi dinil)-14-indol-5-etanosulfonamida.
ES2037278T3 (es) Tratamiento de la esterilidad.
DK88087A (da) Tricyklisk 5-(3-chlor-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo-(c,f)-(1,2)-thiazepin-11-yl)-amino-pentansyrederivat, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende dem
MX6424A (es) Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen.
NO884721L (no) Fremgangsmaate ved fremstilling av biologisk aktive komponenter.
AR240485A1 (es) Composicones activadroas, exentas de titanio,procedimietno para obtenerlas yprocedimiento para activar superfices metalicas antes de su fosfatacion al zionc que emplea dichos fosfatos.
PT94685A (pt) Processo para a preparacao de 2-imidazolinas substituidas e de composicoes farmaceuticas que as contem
IT1213034B (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
ES2108418T3 (es) Oligosacaridos con actividad biologica y preparacion de los mismos a partir de glicosaminoglicanos.
IT1237514B (it) Composti ad attivita' antitussiva, processo per la loro preparazione, loro composizioni farmaceutiche.
Tyroler Nicaraguan President: Abrams' References To Mexico & Peru" warmongering & Disrespectful"
ES2063057T3 (es) Esteres aromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910911

FG3A Patent granted, date of granting

Effective date: 19980504

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20071105